Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile

Jean Camille Mattei(Inserm), Carine Jiguet‐Jiglaire(Centre National de la Recherche Scientifique)

Cancers

March 3, 2020

10.3390/cancers12030583

Cited by 12

Related Papers

Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis

|Immunologic Research|2016|18

Overall survival in patients with re-excision of positive microscopic margins of limb and trunk wall soft tissue sarcoma operated outside of a reference center: a nationwide cohort analysis

|BMC Cancer|2022|14

Improved Metastatic-Free Survival after Systematic Re-Excision Following Complete Macroscopic Unplanned Excision of Limb or Trunk Soft Tissue Sarcoma

|Cancers|2024|7